Pricing Log in Create free account
Saturday 17 October 2026 Export ISRG’s income statement to Excel — free account

Intuitive Surgical, Inc.

ISRG Healthcare Medical Instruments & Supplies

Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.

426.70 1.16 −0.27%
Market cap
$151.2B
P/E
48.3×
Fwd P/E
46.4×
Dividend yield
—
F-score
7/9
Altman Z
50.09
Beneish M
−2.43
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Intuitive Surgical, Inc. (ISRG) EBITDA

Alert me on EBITDA

Intuitive Surgical, Inc.'s EBITDA for fiscal 2025 was $3.6B, up 27.2% from $2.8B in fiscal 2024. Over the twelve months to 30 June 2026 it was $4.3B. Over the past ten years it has ranged from $855.9M (fiscal 2015) to $3.6B (fiscal 2025) — the current reading is the highest in ten years. EBITDA has risen for 3 consecutive fiscal years. Intuitive Surgical, Inc. ranks 3rd of 50 Medical Instruments & Supplies companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $3.6B 27.17%
FY2024 $2.8B 28.22%
FY2023 $2.2B 12.80%
FY2022 $2.0B (8.98%)
FY2021 $2.2B 61.10%
FY2020 $1.3B (15.56%)
FY2019 $1.6B 19.34%
FY2018 $1.3B 13.63%
FY2017 $1.2B 11.50%
FY2016 $1.1B 22.90%

Quarterly newest first

Period EBITDA Change
Jun 2026 $1.2B 14.27%
Mar 2026 $1.0B (1.20%)
Dec 2025 $1.1B 10.57%
Sep 2025 $956.7M 6.52%
42 more quarters

Against its own ten years

Low $855.9M High $3.6B
Ten-year median $1.6B
Current reading's percentile 100

EBITDA against peers

Company EBITDA
MDLN Medline Inc. compare $10.0B
BDX Becton, Dickinson and Company compare $4.8B
ISRG Intuitive Surgical, Inc. $4.3B
ALC Alcon compare $2.7B
SOLV Solventum Corporation compare $2.6B
RMD ResMed Inc. compare $2.1B
BAX Baxter International Inc. compare $1.5B
WST West Pharmaceutical Services, Inc. compare $861.8M
RGEN Repligen Corporation compare $161.0M

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on ISRG